Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 9808481 was granted and assigned to Ritter Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office. | 9808481 | November 7, 2017 | |||||||
Patent 9592248 was granted and assigned to Ritter Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office. | 9592248 | March 14, 2017 | |||||||
Patent 9579340 was granted and assigned to Ritter Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office. | 9579340 | February 28, 2017 | |||||||
Patent 8486668 was granted and assigned to Ritter Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office. | 8486668 | July 16, 2013 | |||||||
Patent 9775860 was granted and assigned to Ritter Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office. | 9775860 | October 3, 2017 | |||||||
Patent 8492124 was granted and assigned to Ritter Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office. | 8492124 | July 23, 2013 | |||||||
Patent 9370532 was granted and assigned to Ritter Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office. | 9370532 | June 21, 2016 | |||||||
Patent 9226933 was granted and assigned to Ritter Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office. | 9226933 | January 5, 2016 | |||||||
8785160 | July 22, 2014 | ||||||||
Patent 11028422 was granted and assigned to Ritter Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office. | 11028422 | June 8, 2021 | |||||||
Patent 7879363 was granted and assigned to Ritter Pharmaceuticals on February, 2011 by the United States Patent and Trademark Office. | 7879363 | February 1, 2011 |